Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Frailty × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 Gynecologic 4 Genitourinary 3 Plasma cell 2 Thoracic 1 Other hematologic neoplasm 1 NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 102 Pheochromocytoma 31 Carcinoma, Neuroendocrine 30 Pituitary Neoplasms 25 Thyroid Cancer, Papillary 24 Paraganglioma 23 Adrenocortical Carcinoma 19 Neoplasms 17 Gastro-enteropancreatic neuroendocrine tumor 17 Thyroid Neoplasms 15 Stomach Neoplasms 14 Pancreatic Neoplasms 14 Adrenal Gland Neoplasms 13 Multiple Endocrine Neoplasia Type 1 12 Thyroid Carcinoma, Anaplastic 11 Prostatic Neoplasms 11 Lung Neoplasms 11 Colorectal Neoplasms 11 Carcinoid Tumor 11 Sarcoma 10 Carcinoma, Hepatocellular 10 Adenoma, Islet Cell 10 Small Cell Lung Carcinoma 9 Ovarian Neoplasms 9 Neoplasm Metastasis 9 Meningioma 9 Esophageal Neoplasms 9 Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Melanoma 8

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡